Akoya Bio­sciences ac­quires Phenop­tics port­fo­lio from Perk­inElmer

BioSpectrum (India) - - SUPPLIER NEWS -

Akoya Bio­sciences, a Tele­graph Hill Part­ners (THP) com­pany, has ac­quired Perk­inElmer, Inc.’s Phenop­tics port­fo­lio. Akoya was founded in 2015 to com­mer­cial­ize the CODEX mul­ti­pa­ram­e­ter tis­sue anal­y­sis tech­nol­ogy de­vel­oped in the lab of Dr Garry Nolan at Stan­ford Univer­sity. Perk­inElmer has grown its Phenop­tics busi­ness, to be an in­dus­try leader in mul­ti­plex im­munoflu­o­res­cence. This ac­qui­si­tion es­tab­lishes Akoya as a lead­ing provider of quan­ti­ta­tive tis­sue biomarker eval­u­a­tion, from dis­cov­ery through trans­la­tional and clin­i­cal re­search. High-pa­ram­e­ter anal­y­sis of bi­o­log­i­cal tis­sue sam­ples pro­vides crit­i­cal spa­tial con­text in stud­ies of au­toim­mune dis­ease, im­mune-on­col­ogy and many other re­search ar­eas. The Phenop­tics port­fo­lio, with its Mantra, Vec­tra and Vec­tra Po­laris sys­tems, pro­vides the through­put and stan­dard­iza­tion re­quired to support largescale trans­la­tional stud­ies. Its mul­ti­spec­tral imag­ing in­stru­ments, reagents, soft­ware and re­search ser­vices have been adopted by hun­dreds of labs glob­ally. CODEX en­ables biomarker dis­cov­ery with de­tec­tion of up to 50 mark­ers on a sin­gle tis­sue sec­tion with reagents and in­stru­men­ta­tion that in­te­grate with our cus­tomer’s ex­ist­ing mi­cro­scopes. CODEX in­cludes op­ti­mized as­say reagents com­bined with val­i­dated an­ti­bod­ies la­beled with pro­pri­etary CODEX Bar­codes to en­able a sim­ple, au­to­mated work­flow.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.